p,p'-Dichlorodiphenyl dichloroethane (DDD)

CASRN 72-54-8

  • IRIS Summary (PDF) (9 pp, 97 K)
  • Status: p,p'-Dichlorodiphenyl dichloroethane (DDD) is not being reassessed by IRIS at this time.

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (9 pp, 97 K)
Not assessed under the IRIS Program.

Reference Concentration for Inhalation Exposure (RfC) (PDF) (9 pp, 97 K)
Not assessed under the IRIS Program.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (9 pp, 97 K) last updated: 08/22/1988

WOE Characterization Framework for WOE Characterization
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) Guidelines for Carcinogen Risk Assessment (US EPA, 1986)
Basis:
  • Based on an increased incidence of lung tumors in male and female mice, liver tumors in male mice and thyroid tumors in male rats. DDD is structurally similar to, and is a known metabolite of DDT, a probable human carcinogen.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (9 pp, 97 K)

Oral Slope Factor: 2.4 x10 -1 per mg/kg-day
Drinking Water Unit Risk: 6.9 x10 -6 per µg/L
Extrapolation Method: Linearized multistage procedure, extra risk
Tumor site(s): Hepatic
Tumor type(s): Liver tumors (Tomatis et al., 1974)


Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (9 pp, 97 K)

Not Assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.